SPC Logo

OLMETEC film-coated tablets

Last Updated on eMC 16-May-2013 View document  | Daiichi Sankyo UK Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 16-May-2013 and displayed until Current

Reasons for adding or updating:

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - use in children/adolescents
  • Change to section 2 - driving and using machines
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store

Updated on 24-Jan-2012 and displayed until 16-May-2013

Reasons for adding or updating:

  • Change due to harmonisation of PIL.

Updated on 10-Nov-2010 and displayed until 24-Jan-2012

Reasons for adding or updating:

  • Change to warnings or special precautions for use

Updated on 05-May-2010 and displayed until 10-Nov-2010

Reasons for adding or updating:

  • Addition of information on alternative format leaflets

Updated on 10-Nov-2009 and displayed until 05-May-2010

Reasons for adding or updating:

  • Change of contra-indications
  • Change to information about pregnancy or lactation

Updated on 17-Jun-2008 and displayed until 10-Nov-2009

Reasons for adding or updating:

  • Addition of joint PIL covering all presentations
  • Change due to user-testing of patient information

Updated on 21-May-2008 and displayed until 17-Jun-2008

Reasons for adding or updating:

  • Transfer to upgraded management system

Updated on 26-Sep-2007 and displayed until 21-May-2008

Reasons for adding or updating:

  • Change to dosage and administration

Updated on 07-Nov-2006 and displayed until 26-Sep-2007

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to how to administer the medicine

Updated on 26-Sep-2006 and displayed until 07-Nov-2006

Reasons for adding or updating:

  • Company name change or merger

Updated on 26-Sep-2006 and displayed until 26-Sep-2006

Reasons for adding or updating:

  • Company name change or merger

Updated on 10-May-2006 and displayed until 26-Sep-2006

Reasons for adding or updating:

  • Change to side-effects

Updated on 01-Mar-2004 and displayed until 10-May-2006

Reasons for adding or updating:

  • Update to PIL

Updated on 27-May-2003 and displayed until 01-Mar-2004

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Daiichi Sankyo UK Limited

Company image
Address

Chiltern Place, Chalfont Park, Gerrards Cross, Buckinghamshire, SL9 0BG, UK

Medical Information Direct Line

+44 (0)1753 482 771

Customer Care direct line

+44 (0)1753 482 771

Out of Hours Telephone

+44 (0)1748 828 818

Telephone

+44 (0)1753 482 771

Medical Information e-mail
Medical Information Fax

+44 (0)1753 893 894

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

olmesartan medoxomil

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.